Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-12

Clinical Trial Update: Antibiofilm Activity of Chitosan Nanoparticles Incorporated Into Clear Aligners [NA]

View source ↗

Summary

Clinical trial investigating antibiofilm activity of chitosan nanoparticles incorporated into clear aligners for Angle Class I malocclusion; status is not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chitosan nanoparticles incorporated into clear aligners (Chitosan nanoparticles)

Snippet

Sponsor: University of Baghdad | Conditions: Malocclusion, Angle Class I | NA | Status: ACTIVE_NOT_RECRUITING